Identification of , a Novel Plasmid-Mediated Fosfomycin Resistance Gene of Origin, in .

Infect Drug Resist

Key Laboratory of Zoonoses, Ministry of Agriculture and Rural Affairs, Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, People's Republic of China.

Published: May 2020

Purpose: Several subtypes of plasmid-mediated fosfomycin resistance gene in have been reported worldwide and have caused concern. The present study characterized a novel member of gene located on a plasmid from .

Materials And Methods: A fosfomycin-resistant isolate PK9 was recovered from a chicken meat sample in 2018. The presence of genes was detected by PCR and sequencing. Whole-genome sequencing (WGS), conjugation, and cloning were performed to identify the mechanism responsible for fosfomycin resistance. Oxford Nanopore MinION sequencing was carried out to characterize the plasmid carrying fosfomycin resistance gene and the genetic context of the novel variant.

Results: A novel gene with significant homology (>98%) with and genes was identified by WGS and was named . FosA10 shared 56.1% to 98.6% amino acid sequence identity with other reported plasmid-mediated FosA enzymes. Fosfomycin resistance and gene were successfully transferred to C600 by conjugation. Cloning confirmed that FosA10 could confer fosfomycin resistance (MIC > 128 μg/mL). The gene was localized on a 53kb IncFII (F35:A-:B-) plasmid. The fragment (4328 bp), located between two copies of IS10R, showed 100% identity with the chromosomal sequences of 17 strains of ST664 and one of ST3821 in GenBank.

Conclusion: Our findings indicated that the gene of might be captured from the chromosome of by IS, which further demonstrated that might act as a reservoir of -like genes acquired by .

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200238PMC
http://dx.doi.org/10.2147/IDR.S251360DOI Listing

Publication Analysis

Top Keywords

fosfomycin resistance
24
resistance gene
16
plasmid-mediated fosfomycin
8
gene
8
conjugation cloning
8
fosfomycin
6
resistance
6
identification novel
4
novel plasmid-mediated
4
gene origin
4

Similar Publications

Efficacy of high doses of intravenous fosfomycin for treatment of urinary tract infection caused by KPC carbapenemase-producing Klebsiella pneumoniae. An observational study.

J Glob Antimicrob Resist

December 2024

Maimonides Biomedical Research Institute of Córdoba (IMIBIC); Microbiology Unit, Reina Sofia University Hospital; Córdoba, Spain; Department of Agricultural Chemistry, Soil Science and Microbiology, University of Cordoba, Cordoba, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

Objectives: To evaluate the efficacy of high-dose intravenous fosfomycin for the treatment of urinary tract infections (UTI) caused by KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp). A secondary objective was to evaluate the impact of the results of fosfomycin susceptibility testing on prognosis.

Methods: This is an observational and retrospective study.

View Article and Find Full Text PDF

Identification of Novel FosX Family Determinants from Diverse Environmental Samples.

J Glob Antimicrob Resist

December 2024

Centre for Antibiotic Resistance Research (CARe)in Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address:

Objectives: This study aimed to identify novel fosfomycin resistance genes across diverse environmental samples, ranging in levels of anthropogenic pollution. We focused on fosfomycin resistance, and given its increasing clinical importance, explored the prevalence of these genes within different environmental contexts.

Methods: Metagenomic DNA was extracted from wastewater and sediment samples collected from sites in India, Sweden, and Antarctica.

View Article and Find Full Text PDF

Background: MDR Gram-negative bacteria, such as ESBL-producing and carbapenemase-producing Klebsiella pneumoniae, represent major global health threats. Treatment options are limited due to increasing resistance and slowed development of novel antimicrobials, making it necessary to apply effective combination therapies based on approved antibiotics.

Objectives: To quantitatively evaluate the synergistic potential of meropenem and fosfomycin against carbapenem-resistant K.

View Article and Find Full Text PDF

Objective: Escherichia coli is isolated in most of uncomplicated community-acquired urinary tract infections (UTI) and fosfomycin is one of the treatments of choice. We analyzed the evolution of fosfomycin resistance in extrahospitalary E. coli urinary isolates and whether age and extended spectrum beta-lactamase (ESBL) production were associated to antibiotic resistance.

View Article and Find Full Text PDF

Background: Carbapenem-resistant Gram-negative bacteria (CR-GNB) develop resistance to many antimicrobials. To effectively manage infections caused by these organisms, novel agents and/or combinations of antimicrobials are required.

Objectives: Evaluated the in vitro efficacy of ceftazidime/avibactam in combination with other antimicrobials against CR-GNB.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!